VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company") today announced that its previously announced special cash dividend (the "Cash Dividend"), declared in connection with the terms and conditions of the Agreement and Plan of Merger and Reorganization, entered into on December 17, 2025, as amended (the "Merger Agreement"), with Yarrow Bioscience, Inc. ("Yarrow") and Yellow Merger Sub Corp., was distributed, in cash, on July 23, 2026 to VYNE’s stockholders of record as of July 22, 2026 (the "Record Date"), subject to the Nasdaq due bill procedures described below, based on their holdings as of the Record Date and during the Due Bill Period (as defined below) and prior to the reverse stock split.

As previously disclosed, VYNE’s reverse stock split at a ratio of 1-for-50 is expected to occur on July 24, 2026. Following the reverse stock split, VYNE’s common stock is expected to begin trading on a post-reverse stock split basis on The Nasdaq Capital Market ("Nasdaq") on July 27, 2026 under CUSIP Number 92941V407 and ISIN Number US92941V4077.